Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-11

Clinical Trial Update: Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response [Phase 4]

View source ↗

Summary

Phase 4 trial update examining durability and impact of seasonal influenza vaccine on H5N1-induced B cell response; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Influenza A Subtype H5N1 Infection | Phase 4 | Status: COMPLETED | Results posted: 2020-03-11